Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Smoldering Multiple Myeloma × Transplantation, Autologous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Smoldering Multiple Myeloma 1 Lymphedema 1 Breast Neoplasms 1

Interventions

Melphalan 2 Transplantation, Autologous 1 Peripheral Blood Stem Cell Transplantation 1 Lenalidomide 1 In Situ Hybridization, Fluorescence 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Dexamethasone 1 Cytogenetic Analysis 1 Cyclophosphamide 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02353572 2015-03-09

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

University of Colorado, Denver

Phase 1/2 Terminated

3 enrolled 5 charts

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡